Galectin Therapeutics (GALT) Return on Equity [ROE] (2011 - 2021)
Galectin Therapeutics' Return on Equity [ROE] was -728.50% in Q4 2021, down 638.74 percentage points from -89.75% a year earlier and down 459.54 percentage points from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Return on Equity [ROE] (2011 - 2021) Analysis & Trends
For FY2021, Return on Equity [ROE] at Galectin Therapeutics came in at -262.51%, down 191.77 percentage points from FY2020.
- Return on Equity [ROE] shows a five-year change of -111.19 percentage points (FY2016 to FY2021).
- In earlier years, Return on Equity [ROE] was -70.74% in FY2020 (-16.53 pp), -54.21% in FY2019 (+544.28 pp), -598.49% in FY2018 (-265.88 pp) and -332.62% in FY2017 (-181.30 pp).
- The Q4 2021 figure marks the lowest quarterly Return on Equity [ROE] since Q1 2018.
- Compared with a year earlier, Return on Equity [ROE] has declined for seven straight quarters, with an average year-over-year change of -123.02 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2019 (a gain of 7636.90 percentage points); the worst was Q1 2018 (a drop of 7655.34 percentage points).
- Per Business Quant data, GALT's Return on Equity [ROE] in the three quarters before Q4 2021 was -268.96% (Q3 2021), -178.10% (Q2 2021) and -134.67% (Q1 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.32% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 7.21% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 84.40% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 21.39% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 83.75% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -18.38% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.97% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 22.24% |
| 10 | Galectin Therapeutics | 257.29 Mn | 257.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -728.50% |
| Sep 30, 2021 | -268.96% |
| Jun 30, 2021 | -178.10% |
| Mar 31, 2021 | -134.67% |
| Dec 31, 2020 | -89.75% |
| Sep 30, 2020 | -63.74% |
| Jun 30, 2020 | -46.10% |
| Mar 31, 2020 | -34.10% |
| Dec 31, 2019 | -29.02% |
| Sep 30, 2019 | -22.95% |
| Jun 30, 2019 | -40.62% |
| Mar 31, 2019 | -233.48% |
| Dec 31, 2018 | -223.83% |
| Sep 30, 2018 | -172.84% |
| Jun 30, 2018 | -331.42% |
| Mar 31, 2018 | -7,870.38% |
| Dec 31, 2017 | -7,780.82% |
| Sep 30, 2017 | -731.76% |
| Jun 30, 2017 | -309.21% |
| Mar 31, 2017 | -215.04% |
API Access
Galectin Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();